HRL wont be testing dead cattle. That will be a loss of business in the short term.
If the government is successful in eradicating the disease, then there will surely be less requirement to test for it in the future.
Also an expected reduction in clearing testing properties raises a big question about future revenues.
This company has been priced for perfection, requiring substantial growth to justify its current share price. It has now become a company with serious questions about the sustainability of the historical revenue.
We should expect a large re-rating now, maybe even back below 10c where it was before the recent acquisition and capital raising.
